Home
/
Peptides
/
VIP Receptor 1 Antagonist / [Ac-His1, D-Phe2, Lys15, Arg16, Leu27]-VIP (1-7) – GRF (8-27)
Verified institutional research accounts only. Supplied for in vitro laboratory research and preclinical studies.
Peptides
VIP Receptor 1 Antagonist / [Ac-His1, D-Phe2, Lys15, Arg16, Leu27]-VIP (1-7) – GRF (8-27)
Catalog No. 064-25
Catalog #: 064-25
Size: 200 µg
Price: $179
Show 1-letter code
Sequence:
Ac-His-D-Ph)-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2
(Ac)H(D)(Ph))DAVFTNSYRKVLKRLSARKLLQDIL(NH2)
Molecular Weight: 3273.9 Purity: ≥ 95% Validation: Exhibits correct molecular weight Solubility: Soluble in water Storage: Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles. Appearance: White powder Contents: Each vial contains 200 µg of NET peptide. Intra-Assay CV: <10% Inter-Assay CV: <15% Sample Extraction: Standard Curve:
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Baldassano S, Wang GD, Mulè F, Wood JD. Am J Physiol Gastrointest Liver Physiol. 2012;302(3):G352-8.
A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Dickson L, Aramori I, Mcculloch J, Sharkey J, Finlayson K. Neuropharmacology. 2006;51(6):1086-98.
Neurogenic secretion mediated by the purinergic P2Y1 receptor in guinea-pig small intestine. Fang X, Hu HZ, Gao N, et al. Eur J Pharmacol. 2006;536(1-2):113-22.
Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. Grimm MC, Newman R, Hassim Z, et al. J Immunol. 2003;171(10):4990-4.
In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Gourlet P, De neef P, Cnudde J, Waelbroeck M, Robberecht P. Peptides. 1997;18(10):1555-60.
Institutional Access
Available only to verified institutional research accounts for in vitro laboratory research and preclinical studies.
Account Eligibility